Moelis & Company (NYSE:MC) finished Thursday with a subtraction of -$2.65 to close at $34.39, a downside of -7.15 percent. An average of 501,730 shares of common stock have been traded in the last five days. There was a fall of -$4.55 in the past week, and it reached a new high 16 times over the past 12 months. The last 20 days have seen an average of 474,837 shares traded, while the 50-day average volume stands at 469,539.
MC stock has decreased by -16.75% in the last month. The company shares reached their 1-month lowest point of $33.12 on 09/23/22. With the stock rallying to its 52-week high on 01/04/22, shares of the company touched a low of $36.69 and a high of $76.19 in 52 weeks. It has reached a new high 2 times so far this year and lost -40.75% or -$27.92 in price. In spite of this, the price is down -54.86% from the 52-week high.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now.
115 days have passed since Moelis & Company (MC) last reported insider trading activity. CRAIN ELIZABETH, who is Chief Operating Officer, most recently acquired $7,000 shares at $47.08 per share on May 31. In this transaction, the insider spent $329,560. Chief Operating Officer, CRAIN ELIZABETH, disposed of 7,116 shares at a price of $44.61 on May 25. The insider now owns more than $317,445 worth of shares. Prior to that, General Counsel, Secretary WATANABE OSAMU R. went on to Sale 6,232 shares at $47.12 each on Feb 22. An amount of $293,652 was transacted.
Moelis & Company (MC) has a trailing price-to-earnings (P/E) ratio of 7.95. The stock’s beta is 1.31. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 1.75, the price-to-book (PB) ratio at 5.65, and the price-to-cash flow ratio at 19.49.
The company has a payout ratio of 35.80%. The company’s most recent quarterly dividend payment was $0.60 a share, without any change from last year. Its latest decrease dividend $2.50 reported on Thursday February 10 2022.
Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 for the quarter ending June 29. Its gross profit as reported stood at $495.92 million compared to revenue of $1.54 billion.
In the quarter under review, the net income was down than the previous quarter. The company posted a net income of $38.96 million in the quarter, while revenues of $65.72 million were shrunk -103.64%. The analyst consensus anticipated Moelis & Company’s latest quarter earnings to come in at $0.43 per share, but it turned out to be $0.57, a 32.60% surprise. For the quarter, EBITDA amounted to $64.04 million. At the end of the quarter ending June 29, Moelis & Company’s stock balance sheet showed total debt was $196.37 million. Shareholders own equity worth $68.76 million.
From a technical analysis perspective, let’s take a brief look at Moelis & Company (MC) price momentum. RSI 9-day as of the close on 22 September was 18.00%, suggesting the stock is oversold, with historical volatility in this time frame at 42.92%.
As of today, MC’s price is $37.59 -11.62% or -$4.55 from its 5-day moving average. MC is currently trading -22.96% lower than its 20-day SMA and -23.25% lower than its 100-day SMA. However, the stock’s current price level is -11.15% below the SMA50 and -44.87% below the SMA200.
The stochastic %K and %D were 6.35% and 8.79%, respectively, and the average true range (ATR) was 1.71. With the 14-day stochastic at 13.30% and the average true range at 1.57, the RSI (14) stands at 23.95%. The stock has reached -1.81 on the 9-day MACD Oscillator while the 14-day reading was at -3.17.
UBS downgraded Moelis & Company (NYSE: MC) to a a Sell rating in its most recent analyst report. Previously, the stock was rated as a Neutral. The consensus rating for Moelis & Company (MC) among analysts is Underweight. According to current brokerage recommendations, 3 brokerage firms advise that investors sell MC, while 5 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 0 others rate it as a “buy”.
What is MC’s price target for the next 12 months?
Analysts predict a range of price targets between $35.00 and $52.00, with a median target of $42.50. Taking a look at these predictions, the average price target given by analysts for Moelis & Company (MC) stock is $42.17.